IP Verse

Alexion Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Alexion Pharmaceuticals, Inc.

Patent Number:
EP2708559
Title:
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Dec 31, 2018
Patent Number:
EP2708558
Title:
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Dec 21, 2018
Patent Number:
EP2552955
Title:
Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Feb 2, 2018

Latest patents of Alexion Pharmaceuticals, Inc. opposed by its competitors

Patent:
EP3167888
Grant Date:
May 1, 2024
Title:
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
Oppositions:
1
Patent:
EP2894165
Grant Date:
Jan 4, 2023
Title:
Methods And Compositions For Treating Complement-Associated Disorders
Oppositions:
2
Patent:
EP2978451
Grant Date:
Nov 27, 2019
Title:
Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C5
Oppositions:
2
Patent:
EP3207132
Grant Date:
Jul 31, 2019
Title:
Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof
Oppositions:
1

Competitors of Alexion Pharmaceuticals, Inc.

CHUGAI SEIYAKU KABUSHIKI KAISHA

ALNYLAM PHARMACEUTICALS, INC.

AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY

Want to track Alexion Pharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you